Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
F A Allaert, C Hugue, M Cazaubon, J M Renaudin, T Clavel, P Escourrou
Index: Int. Angiol. 30(3) , 272-7, (2011)
Full Text: HTML
Abstract
The aim of this study was to compare the change in functional signs of venous insufficiency and venous refilling time measured by mercury strain-gauge plethysmography under the effects of the combination of Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid (Cyclo 3 Fort).An open-label clinical trial conducted in 65 women presenting with CEAP class C2s and C3s assessment criteria. At D0 and D28, functional signs were measured on a visual analog scale (VAS), venous refilling time by mercury strain-gauge plethysmography and venous reflux by echo-Doppler method.Under treatment, venous refilling time increased from 11.7±4 s to 13.8±4.4 s with Δ of 26% (P<0.0001) and the percentage of patients showing improvement of functional symptoms ≥30% was significantly correlated (P=0.04) with the percentage of patients presenting an improvement in venous refilling time ≥10%.Improvement in subjective functional signs under treatment with Cyclo 3 Fort was correlated with objective plethysmographic parameter improvement. There-fore, this study contributes to objectively document the benefit of prescribing this venoactive drug to active women with CEAP class C2s to C3s.
Related Compounds
Related Articles:
Assessment of the antineoplastic potential of chalcones in animal models.
2013-01-01
[Curr. Med. Chem. 20(2) , 186-221, (2013)]
Absorption and elimination of (14C) hesperidin methylchalcone in the rat.
1981-01-01
[Eur. J. Drug Metab. Pharmacokinet. 6(3) , 171-7, (1981)]
1993-08-01
[J. Cardiovasc. Pharmacol. 22(2) , 225-30, (1993)]
2008-05-01
[Int. Immunopharmacol. 8(5) , 670-8, (2008)]
1999-12-01
[Int. Angiol. 18(4) , 306-12, (1999)]